Switch theme
Sign up to access all valuation multiples
Penumbra Inc develops and manufactures medical devices for the neurovascular and peripheral vascular markets. Its products are sold to hospitals and are developed for use by specialist physicians. Within the neurovascular business, the firm offers products for neurovascular access, ischemic stroke, neurovascular embolization, and neurosurgical tool markets. In the peripheral vascular business, the firm sells devices related to peripheral embolization and peripheral thrombectomy. It operates as one reportable segment and its business activity consists of the design, development, manufacturing and marketing of inventive medical products.
2004
4.5K+
LTM Revenue $1.2B
LTM EBITDA $179M
$11.4B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Penumbra has a last 12-month revenue of $1.2B and a last 12-month EBITDA of $179M.
In the most recent fiscal year, Penumbra achieved revenue of $1.2B and an EBITDA of $46.0M.
Penumbra expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Penumbra valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $1.1B | $1.2B | XXX | XXX | XXX |
| Gross Profit | $535M | $683M | XXX | XXX | XXX |
| Gross Margin | 51% | 57% | XXX | XXX | XXX |
| EBITDA | $109M | $46.0M | XXX | XXX | XXX |
| EBITDA Margin | 10% | 4% | XXX | XXX | XXX |
| Net Profit | -$2.0M | $91.0M | XXX | XXX | XXX |
| Net Margin | 0% | 8% | XXX | XXX | XXX |
| Net Debt | n/a | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 25, 2025, Penumbra's stock price is $298.
Penumbra has current market cap of $11.6B, and EV of $11.4B.
See Penumbra trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $11.4B | $11.6B | XXX | XXX | XXX | XXX | $2.71 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 25, 2025, Penumbra has market cap of $11.6B and EV of $11.4B.
Penumbra's trades at 9.1x LTM EV/Revenue multiple, and 63.8x LTM EBITDA.
Analysts estimate Penumbra's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Penumbra and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $11.4B | XXX | XXX | XXX |
| EV/Revenue | 9.5x | XXX | XXX | XXX |
| EV/EBITDA | 247.7x | XXX | XXX | XXX |
| P/E | 824.3x | XXX | XXX | XXX |
| P/E/Growth | 3.0x | XXX | XXX | XXX |
| EV/FCF | 77.3x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpPenumbra's NTM/LTM revenue growth is 13%
Penumbra's revenue per employee for the last fiscal year averaged $0.3M, while opex per employee averaged $0.1M for the same period.
Over next 12 months, Penumbra's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Penumbra's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Penumbra and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | 13% | XXX | XXX | XXX | XXX |
| EBITDA Margin | 4% | XXX | XXX | XXX | XXX |
| EBITDA Growth | -58% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | 17% | XXX | XXX | XXX | XXX |
| Revenue per Employee | $0.3M | XXX | XXX | XXX | XXX |
| Opex per Employee | $0.1M | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | 8% | XXX | XXX | XXX | XXX |
| Opex to Revenue | 56% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Philips | XXX | XXX | XXX | XXX | XXX | XXX |
| Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
| InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
| Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Penumbra acquired XXX companies to date.
Last acquisition by Penumbra was XXXXXXXX, XXXXX XXXXX XXXXXX . Penumbra acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was Penumbra founded? | Penumbra was founded in 2004. |
| Where is Penumbra headquartered? | Penumbra is headquartered in United States of America. |
| How many employees does Penumbra have? | As of today, Penumbra has 4.5K+ employees. |
| Who is the CEO of Penumbra? | Penumbra's CEO is Mr. Adam Elsesser. |
| Is Penumbra publicy listed? | Yes, Penumbra is a public company listed on NYS. |
| What is the stock symbol of Penumbra? | Penumbra trades under PEN ticker. |
| When did Penumbra go public? | Penumbra went public in 2015. |
| Who are competitors of Penumbra? | Similar companies to Penumbra include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
| What is the current market cap of Penumbra? | Penumbra's current market cap is $11.6B |
| What is the current revenue of Penumbra? | Penumbra's last 12-month revenue is $1.2B. |
| What is the current EBITDA of Penumbra? | Penumbra's last 12-month EBITDA is $179M. |
| What is the current EV/Revenue multiple of Penumbra? | Current revenue multiple of Penumbra is 9.1x. |
| What is the current EV/EBITDA multiple of Penumbra? | Current EBITDA multiple of Penumbra is 63.8x. |
| What is the current revenue growth of Penumbra? | Penumbra revenue growth between 2023 and 2024 was 13%. |
| Is Penumbra profitable? | Yes, Penumbra is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
